The Value of Serum Elabela in Preeclamptic Women with and without Fetal Growth Restriction at 34 Weeks of Pregnancy: A Case–Control Study

Background: Reliable screening methods for fetal growth restriction (FGR) are crucial to improve maternal and neonatal outcomes. Preeclampsia (PE) is a specific pregnancy ailment that contributes to FGR. Elabela (Ela), a newly discovered adipokine, was correlated with PE. Objective: As a marker of P...

詳細記述

書誌詳細

出版年:	Medical Journal of Babylon
主要な著者:	Eham Amer Ali, Amenah Fadhil, Shaymaa Khalid Abdulqader, Wassan Nori, Mustafa Ali Kassim Kassim, Alexandru Cosmin Pantazi
フォーマット:	論文
言語:	英語
出版事項:	Wolters Kluwer Medknow Publications 2025-01-01
主題:	fetal growth restriction fetal weight preeclampsia pulsatility index serum elabela
オンライン･アクセス:	https://doi.org/10.4103/MJBL.MJBL_1375_23